A multi-institutional study led by researchers at UNC Lineberger Comprehensive Cancer Center, the Salk Institute for Biological Studies, and UC San Diego has uncovered new genetic rules that determine ...
Clinical Trials Arena on MSN
Biosion doses first patient in phase Ia/Ib BSI-082 trial for solid tumours
The trial is conducted at the Mays Cancer Center, part of the University of Texas at San Antonio’s Health Science Center.
This image shows killer T cells surrounding and attacking a cancer cell. A new atlas developed by researchers at UC San Diego could make it possible to design custom T cells for immunotherapy to ...
CHAPEL HILL, N.C. - Feb. 4, 2026 - A multi-institutional study led by researchers at UNC Lineberger Comprehensive Cancer Center, the Salk Institute ...
Early Phase 2a data suggest the IPF therapy GRI-0621 alters gene activity tied to inflammation, scarring, and tissue repair.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果